Turneer M, Van Vooren J P, De Bruyn J, Serruys E, Dierckx P, Yernault J C
Institut Pasteur du Brabant, Brussels, Belgium.
J Clin Microbiol. 1988 Sep;26(9):1714-9. doi: 10.1128/jcm.26.9.1714-1719.1988.
The P32 protein antigen of Mycobacterium bovis BCG, identified as antigen 85A in the BCG reference system, was used to investigate the humoral immune response in human tuberculosis (TB). Immunoglobulin G (IgG), IgA, and IgM directed against P32 were measured by an enzyme-linked immunosorbent assay. Mean IgG and IgA antibody levels differed significantly (P less than 0.001) between active-TB patients (50 untreated and 52 treated) and healthy control subjects (111 unvaccinated tuberculin negative, 38 unvaccinated tuberculin positive, and 72 recently BCG vaccinated). Mean IgG antibody levels, but not mean IgA antibody levels, were higher (P less than 0.05) in patients with positive microscopic examination for acid-fast bacilli than in patients with negative microscopic examination. A positive relation was found between mean levels and the extent of disease. There was no difference in mean IgM antibody levels between patients and controls. By setting the upper normal limit at the 95th percentile of the 221 healthy subjects, the sensitivities were 46% in untreated and 63% in treated patients for IgG and 30 and 50%, respectively, for IgA. Of the untreated patients, 56% were positive for either IgG or IgA antibodies. Among the untreated patients with negative direct smear, 35% were positive for IgG and 24% were positive for IgA. When both immunoglobulin classes were combined, the serological test was positive in 47% of those patients. Neither naturally acquired tuberculin hypersensitivity nor BCG vaccination affected positivity frequencies in healthy subjects. Only active TB seemed to induce significant anti-P32 antibody levels and to be associated with positivity. A serological test with P32 as the antigen might therefore be helpful for the rapid diagnosis of TB.
牛分枝杆菌卡介苗(BCG)的P32蛋白抗原,在BCG参考系统中被鉴定为抗原85A,用于研究人类结核病(TB)中的体液免疫反应。通过酶联免疫吸附测定法检测针对P32的免疫球蛋白G(IgG)、IgA和IgM。活动性TB患者(50例未治疗和52例已治疗)与健康对照者(111例未接种卡介苗结核菌素阴性、38例未接种卡介苗结核菌素阳性和72例近期接种BCG)之间的平均IgG和IgA抗体水平差异显著(P小于0.001)。抗酸杆菌显微镜检查阳性的患者,其平均IgG抗体水平高于显微镜检查阴性的患者(P小于0.05),但平均IgA抗体水平无差异。平均水平与疾病程度之间存在正相关。患者与对照者的平均IgM抗体水平无差异。将221名健康受试者的第95百分位数设定为正常上限,未治疗患者中IgG的敏感性为46%,治疗患者中为63%;IgA的敏感性分别为30%和50%。未治疗患者中,56%的患者IgG或IgA抗体呈阳性。在直接涂片阴性的未治疗患者中,35%的患者IgG呈阳性,24%的患者IgA呈阳性。当两种免疫球蛋白类别结合时,47%的患者血清学检测呈阳性。自然获得的结核菌素超敏反应和BCG接种均不影响健康受试者的阳性频率。似乎只有活动性TB会诱导显著的抗P32抗体水平并与阳性结果相关。因此,以P32为抗原的血清学检测可能有助于TB的快速诊断。